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ScienceDirectDesigning putative metabolic pathways is of great interest in
synthetic biology. Retrobiosynthesis is a discipline that
involves the design, evaluation, and optimization of de novo
biosynthetic pathways for the production of high-value
compounds and drugs from renewable resources and natural
or engineered enzymes. The best candidate pathways are
then engineered within a metabolic network of
microorganisms that serve as synthetic platforms for synthetic
biology. The complexity of biological chemistry and
metabolism requires computational approaches to explore the
full possibilities of engineering synthetic pathways towards
target compounds. Herein, we discuss recent developments
in the design of computational tools for retrosynthetic
biochemistry  and outline the workflow and design elements for
such tools.
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Introduction
One of the principal aims of synthetic biology and
metabolic engineering is to design and build microbial
factories for the sustainable fabrication of high-value
compounds and industrial chemicals [1–4]. To create
efficient microbial factories and broaden the range of
biosynthetic pathways for the production of both natural
and non-natural compounds, it is necessary to go beyond
natural pathways by exploring the chemistry and synthet-
ic capabilities of biological systems [1,5]. The de novo
design of pathways is crucial for exploiting the incredible
natural diversity of enzymatic transformations.
Retrobiosynthesis, a promising approach for de novo path-
way design, is inspired by the retro-evolution hypothesiswww.sciencedirect.com that was first proposed in 1945 by Norman Horowitz [6,7]
and has its origins in retrosynthetic organic chemistry.
Retrosynthetic design starts by defining a target molecule
of interest to produce and then ‘walks’ backwards through
the known chemical transformation rules to modify the
target molecule and identify potential precursors and
reactions [8,9].
This basic concept of walking backwards from a molecule
and using the biotransformation rules to reconstruct bio-
chemical pathways is also used: (i) to find novel pathways
for the biodegradation of pollutants [10,11] to generate
hypothetical pathways for metabolites and lipids that are
found in metabolomics and lipidomics studies, but have
an unknown metabolism [12]. Although retrosynthesis
and retrobiosynthesis are molecular design methods, the
term retrobiosynthesis was also initially used to describe
the analysis of experimental 13C labeling data for identi-
fying biosynthetic routes [13].
In retrobiosynthesis, the aim is to produce a target mole-
cule through enzymatic biotransformation steps that oc-
cur in a metabolic pathway of microorganisms. This
analysis results in de novo pathways that connect the
target molecule to either a cellular metabolite or a bio-
chemical feedstock using natural or engineered enzymes.
Before a de novo pathway can be built in the laboratory
and integrated in a microorganism, it should first be
designed and evaluated. Although intuition and manual
design can assist in postulating novel pathways, these are
not sufficient to guarantee the generation of all potentials
and to select the most efficient ones [1,2,14–19]. Hence,
computational prediction tools are indispensible for retro-
biosynthesis analysis, not only for assisting with generat-
ing novel hypotheses but also for screening for the most
efficient pathways. Computational frameworks result in
the extensive generation of all possible de novo biosyn-
thetic pathways to allow for the exploration of the entire
realm of feasible biotransformations in a given cell
[11,18–23,24,25,26].
The combinatorial explosion is the most important risk
associated with computational approaches, as these meth-
ods generate compounds and reactions that may or may
not actually occur in nature. Therefore, the next crucial
step is to screen the generated biosynthetic pathways
through feasibility studies. Various techniques can be
used to prune the de novo generated pathways and select
the most promising ones. In the next sections, we discussCurrent Opinion in Chemical Biology 2015, 28:99–104
100 Synthetic biologythe general workflow and essential design elements to be
integrated into the development of a sound framework for
retrobiosynthetic studies, and we compare different avail-
able tools based on the consideration of these elements.
From our experience in developing the retrobiosynthesis
framework BNICE.ch and the analysis of other available
tools, we propose a retrobiosynthetic workflow that
includes three main steps, and each step requires the
implementation of certain technical design elements
(Figure 1).
In silico pathway design
The most common in silico pathway prediction tools offer
the enumeration of pathways in two ways: either they
effectively combine known reactions from databases that
lead to the production of a desired compound from
different organisms (heterologous pathways) [23,27–29]
or they construct de novo pathways that include not only
known reactions but also hypothetical steps whose corre-
sponding enzymes might not actually exist in nature
[11,18,19,22,24,25,30]. A comprehensive algorithm
for the in silico prediction of de novo pathways is a
significant driver for the success of retrobiosyntheticFigure 1
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in the past decade (Table 1).
One of the key design elements of the BNICE.ch tool is a
database of ‘biochemical transformation rules’ that mimic
the functions of enzymes and serve as in silico enzymatic
reactions. As there are a large number of characterized
enzymes, one can organize those that employ similar
reaction mechanisms into ‘generalized enzymatic reaction
rules’ [19,20]. The concept of generalized reaction rules
has been adopted by several other similar methods
[18,22,24,25,26]. When acting on a molecule, the gen-
eralized reaction rules recognize the biologically reactive
sites of a molecule and apply the biotransformation,
whereby atoms and bonds rearrange to form a product.
Therefore, a generalized rule is capable of acting upon a
wide range of substrates in addition to specific native
substrates. This leads to the identification of candidate
sequences for designing enzymes with broad or altered
substrate specificities.
Repeating this process iteratively using a ‘network gener-
ation algorithm’ results in the generation of a biochemical
network of all theoretically possible compounds and reac-
tions, including those that have no known experimentale
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Table 1
Available retrobiosynthesis tools and their characteristics
Tools Generalized
reaction
rules
De novo
reaction
Gibbs free
energy of
formation
and reaction
Network
thermodynamics
Protein sequence
identification
based on enzyme
promiscuity and
reaction similarity
Enzyme
docking
Host
organism
specificity
Pathways
scoring
and
ranking
Tool
development
and
applications
BNICE.ch U U U U U U U [12,19–21,31,32]
DESHARKY U U U U [23,33]
ReBiT
http://www.retro-
biosynthesis.com
U U U U [26]
Method developed
with Cho et al.
U U U U [18]
RetroPath
http://www.issb.
genopole.fr/
~faulon/retropath.php
U U U U U U [14,22,34,35,36,37]
SimPheny U U U U U U [24]
GEM-Path U U U U U U [25]counterpart (de novo compounds and reactions). The
next required design element is a ‘pathway reconstruc-
tion algorithm’ that constructs all possible pathways
from a given substrate to a target molecule. These
algorithms perform either a graph-based search in the
network or use optimization-based methods to identify
possible pathways from potential substrates for the
synthesis of a target compound in the generated meta-
bolic network [31,38,39].
Pruning the generated data
A retrobiosynthetic analysis risks a combinatorial explo-
sion in two ways. First, in the network generation process,
the actions of generalized reaction rules on the target
compound results in the generation of all possible com-
pounds and reactions, which may or may not actually
occur in nature and exponentially increase in every itera-
tion of the network generation algorithm. Second, be-
cause of the combinatorial nature of the pathway
enumeration step, an enormous number of pathways from
a substrate to the same target compound are generated.
Thus, the very important next step is the evaluation of the
proposed compounds, reactions, and pathways and the
selection of the most feasible enzymes, reactions, and
pathways to be tested in the laboratory. Pruning analysis
is performed using two strategies:
(1) Qualitative pruning of generated data;
(2) Quantitative pruning of generated pathways.
Qualitative pruning of generated results
Qualitative pruning of the generated pathways is the
process of surveying which fraction of the obtained infor-
mation is already known or novel and asking how similar iswww.sciencedirect.com the novel information compared with the known data, i.e.,
the metabolites, reactions and pathways in the databases.
These databases are biological, such as KEGG [40] and
Metacyc [41], and chemical such as PubChem [42] and
ChEBI [43]. Qualitative pruning in general is indepen-
dent of the organism of choice and is done by comparing
the metabolites and reactions in the synthetic pathways
with the entries in existing databases. By screening
through existing databases, not only can we differentiate
between known and novel knowledge, but we can also
directly capture available biochemical properties for the
compounds and reactions. One such property, as imple-
mented in RetroPath for the qualitative pruning of de novo
pathways, is the toxicity of known reactants and products
of reactions [14,36].
Qualitative pruning in the network generation step
In the network generation algorithm, screening against
databases is most commonly carried out after pathway
reconstruction. In BNICE.ch, we have also introduced
the notion of supervised network generation through the
adaptable search space in the de novo pathway prediction
process. The adoptable search space allows searching
within a domain of metabolites and reactions that are
predefined as a parameter, and the supervision can be
applied for the generated compounds or reactions, or
both, leading to the following features:
 Selection of the compound search space:
where in each iteration, we keep only those compounds
that are part of a biological or chemical database, or
both (vs keeping all known and novel compounds in
each iteration).
 Selection of the reaction search space:Current Opinion in Chemical Biology 2015, 28:99–104
102 Synthetic biologywhere in each iteration, we allow only known KEGG
reactions or reactions that are part of a specific database
(vs keeping all known and novel reactions in each
iteration).
These features can also be implemented in every network
generation algorithm for the efficient organization of
results based on the knowledge that exists in databases
and to address the risk of combinatorial explosion.
Qualitative pruning in the pathway enumeration step
The complications that arise from the huge number of
generated pathways resulting in the existing pathway
enumeration methods has been previously discussed
[14,39,44] and solutions have been proposed to enumer-
ate ‘a set of viable pathways’ based on predefined criteria,
rather than all possible pathways.
In BNICE.ch, we have also implemented the notion of
supervised pathway enumeration to evaluate pathways
based on our knowledge of compounds and reactions in
databases. For example, we can enumerate only path-
ways with a prespecified percentage of their steps
existing in biological databases as known enzymatic
reactions.
Protein sequence identification for de novo reactions
A compelling aspect of the interactive analysis with
databases is the structural similarity comparison of sub-
strates and products of de novo reactions with the sub-
strates and products of known reactions. The results of
such a comparison could be quantified using different
chemoinformatics metrics, such as ‘compound finger-
print comparison’ using the ‘Tanimoto distance’ and
assigning to novel reactions a similarity score with re-
spect to the existing reactions. Using such a metric, one
can identify gene and protein sequences for the de novo
steps of a pathway based on their structural similarities
to known reactions. The enzymes encoded by those
genes might be able to catalyze novel reactions but with
very low activity, or they might perform very similar
catalysis reactions, as they will belong to the same 3rd
level in the Enzyme Commission (EC) classification
system. Therefore, one must use evolution-based pro-
tein engineering and computational protein design
[32] to obtain sequences and enzymes for the experi-
mental implementation of novel pathways with signifi-
cant performance [7,45].
Quantitative pruning of generated pathways
Once we enumerate de novo pathways of interest and
screen them against databases, the next step is to perform
a feasibility analysis to determine the fitness and perfor-
mance of individual pathways and to quantitatively prune
the proposed pathways down to a set of the most biologi-
cally feasible ones. Quantitative pruning is generally
context-dependent for the chassis organism. DifferentCurrent Opinion in Chemical Biology 2015, 28:99–104 metrics can be applied to evaluate the likelihood of an
in silico-designed pathway being proficiently implemen-
ted in an organism.
One crucial metric is the thermodynamics of the reaction
steps and consequently the synthetic pathway to allow us
to discard those pathways that are energetically unfavor-
able. To perform such a thermodynamics analysis, we
developed a Group Contribution Method to estimate the
Gibbs free energy for metabolites and consequently for
reactions [46]. This method has been used in several
frameworks to estimate the thermodynamics feasibility of
the in silico generated synthetic pathways [18,24,25].
Furthermore, in BNICE.ch, we apply constraint-based
modeling by incorporating the synthetic pathways one at
a time into the genome scale model of chosen organism
and performing Thermodynamics-based Flux Balance
Analysis (TFBA) [47,48]. This additional step allows us
to adjust the estimated Gibbs free energy based on the
metabolite concentration, ionic strength, and pH to get
closer to in vivo conditions. By performing a TFBA
analysis, we guarantee that the obtained pathways are
feasible with respect to mass balance (stoichiometrically),
we assess the network thermodynamic feasibility of the
generated pathways and we eventually quantify their
overall effects on the metabolic profile of the organism
by calculating the energetic cost and changes in the
biomass yield for each molecule of the generated product
[49,50]. One of the most important outcomes of TFBA for
biotechnological applications is also the pruning and
ranking of pathways based on the maximum production
yield of the target molecule from each individual syn-
thetic pathway. Other practical aspects have been also
used for the quantitative pruning of de novo pathways,
such as enzyme kinetics and gene compatibility
[35,36,51].
Scoring and ranking the biosynthetic
pathways
By reconciling the metrics obtained in the qualitative and
quantitative pruning strategies, one can define a scoring
and ranking feature that combines and scales different
factors and assigns an overall score for the prioritization of
in silico generated pathways. Such a score gives the
capability of pinpointing the best candidate synthetic
pathways that are most likely to produce a desired target
molecule and can be implemented in the metabolic
network of the chassis organism. Additionally, one can
rank the scores for a certain criterion as the primary
ranking, and then perform a secondary ranking based
on another criterion. For instance, choosing pathways
with a maximum (or economically feasible) yield, and
from those pathways choosing those with a minimum
number of novel reactions, since their implementation
will involve a smaller number of engineering enzyme
steps.www.sciencedirect.com
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Computational retrobiosynthesis tools feature de novo
pathway design and prioritization for synthetic biology
and metabolic engineering studies.
Pruning approaches are crucial to avoid the risk of com-
binatorial explosion in the enumeration of de novo path-
ways. Here, we systematically classified the established
methods and proposed strategies for pruning the gener-
ated de novo pathways.
One should be careful when applying certain criteria used
for pruning the obtained data, recognizing that this is a
multi-objective problem and different applications might
give different weights to different criteria. Moreover,
some of these criteria depend upon current technologies,
and although some pathways can be currently ruled as
infeasible, new technologies could enable their realiza-
tion in the future.
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